RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Athira Pharma Stock

Athira Pharma Market capitalization 2024

Athira Pharma Market capitalization

17.11 M USD

Ticker

ATHA

ISIN

US04746L1044

WKN

A2QCFW

In 2024, Athira Pharma's market cap stood at 17.11 M USD, a -73.12% increase from the 63.65 M USD market cap in the previous year.

The Athira Pharma Market capitalization history

YEARMarket Capitalization (undefined USD)
202398.73
2022246.75
2021657.48
2020738.92
2019-
2018-

Athira Pharma Aktienanalyse

What does Athira Pharma do?

Athira Pharma Inc. is a biopharmaceutical company founded in 2011 and based in Seattle, USA. The company focuses on the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The strategy of Athira is to develop therapies for the treatment of diseases of the central nervous system and the regeneration of tissues that have been damaged by injuries or aging, based on RNA-based technologies. This work is carried out by an experienced team of scientists and executives. Athira's business model is based on the goal of developing innovative and personalized drug therapies to prevent, slow down, or specifically treat diseases. The company pursues an evidence-based approach called "patient-centered approach." Athira aims to understand the cause of certain diseases and develop targeted therapies that aim to treat that cause. Athira's research and development area consists of three units: 1. Neurology: This division focuses on the development of therapies for the treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis. The company has already developed a drug candidate that is in an extended phase I/II clinical trial and shows potential for the treatment of Alzheimer's dementia. 2. Regeneration: The regeneration division mainly deals with the regeneration of nerve cells and tissues in the body. This area has the potential to develop therapies for the treatment of spinal cord injuries and degenerative diseases of the body. 3. Platform technology: Athira's platform technologies are based on RNA interference technology, which aims to experimentally silence genes. The platform technology aims to identify and validate cell-specific RNA targets that can address a wide range of diseases. Athira specializes in the research and development of innovative therapies with the goal of defeating diseases and improving patients' health. The company has achieved significant successes in recent years, positioning itself as an important player in the industry. The market for therapies for the treatment of neurodegenerative diseases offers immense opportunities and potentials as these diseases are expected to increase in the future due to the aging population. Athira sees itself well positioned to take on the challenges in the industry and continue to develop innovative solutions for the treatment of diseases. Athira Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Athira Pharma's Market Capitalization

Athira Pharma's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Athira Pharma's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Athira Pharma's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Athira Pharma’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Athira Pharma stock

What is the current Athira Pharma market capitalization?

The current market capitalization of Athira Pharma is 17.11 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Athira Pharma.

How has the market capitalization of Athira Pharma developed in recent years?

The market capitalization of Athira Pharma has increased/decreased by -73.12% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Athira Pharma?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Athira Pharma?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Athira Pharma have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Athira Pharma pay?

Over the past 12 months, Athira Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athira Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Athira Pharma?

The current dividend yield of Athira Pharma is .

When does Athira Pharma pay dividends?

Athira Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Athira Pharma?

Athira Pharma paid dividends every year for the past 0 years.

What is the dividend of Athira Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Athira Pharma located?

Athira Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Athira Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Athira Pharma from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Athira Pharma pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Athira Pharma in the year 2023?

In the year 2023, Athira Pharma distributed 0 USD as dividends.

In which currency does Athira Pharma pay out the dividend?

The dividends of Athira Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Athira Pharma

Our stock analysis for Athira Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athira Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.